Drug Testing

Drug Testing for Kratom in the Workplace

Standard workplace drug tests typically do not screen for kratom or its active compounds, such as mitragynine and 7-hydroxymitragynine. Specialized tests are required to detect kratom in biological samples. Employers may choose to include kratom in their drug panels, especially if there are specific concerns or policies in place.

Medically reviewed · Evidence-basedBy Benjamin Zohar, NCACIP · Reviewed by Brandon McNally, RNPublished · Updated · Last reviewed

Kratom Detection Methods

Detecting kratom in biological samples requires specific analytical techniques because its primary active compounds, mitragynine and 7-hydroxymitragynine (7-OH), are not typically included in standard drug screening panels. These compounds are structurally different from commonly tested substances like opiates or cannabinoids, necessitating specialized assays.

Laboratories that offer kratom testing often employ advanced methods such as gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS). These techniques are highly sensitive and specific, capable of identifying and quantifying kratom alkaloids even at low concentrations.

Types of Tests Used for Kratom

Several types of biological samples can be analyzed for the presence of kratom alkaloids. The choice of sample often depends on factors such as the detection window required and the ease of collection. Each method has its own advantages and limitations regarding detection timeframes.

The most common types of tests used for kratom detection include:

  • Urine tests: These are the most frequently used method due to their non-invasive nature and relatively good detection window. They can typically detect kratom metabolites for several days after last use.
  • Blood tests: While less common for routine screening, blood tests offer a shorter detection window, usually hours to a day or two, and can indicate recent use.
  • Hair follicle tests: These tests have the longest detection window, potentially identifying kratom use for up to 90 days. They are often used for chronic use detection.
  • Saliva tests: Similar to blood tests, saliva tests offer a shorter detection window, typically within a day or two of use.

Factors Influencing Kratom Detection Windows

The length of time kratom remains detectable in a person's system can vary significantly. Several factors influence the detection window, making it difficult to provide an exact timeframe for every individual. These factors highlight the complexity of drug metabolism and elimination.

Key factors affecting detection windows include an individual's metabolism, the amount and frequency of kratom used, hydration levels, and overall health. Generally, occasional users may clear kratom from their system faster than chronic or heavy users. More research is needed to fully understand all variables.

Employer Policies Regarding Kratom Testing

Employers are generally not required to test for kratom, as it is not a federally controlled substance. However, some employers, particularly those in safety-sensitive industries or those with comprehensive drug-free workplace programs, may choose to include kratom in their drug testing panels. This decision is often based on company policy, industry regulations, or specific concerns about employee impairment.

It is crucial for employees and job applicants to understand their employer's drug testing policies. These policies should be clearly communicated and may outline which substances are tested for, the types of tests used, and the consequences of a positive result. If you are concerned about kratom use, seeking professional guidance can be a beneficial step.

Frequently Asked Questions

Author

Benjamin Zohar, NCACIP

Nationally Certified Advanced Clinical Intervention Professional (NCACIP) · NAADAC Member · ISSUP Network Moderator

Benjamin Zohar is an addiction recovery professional, NAADAC member, and founder of Intervention New York (Intervention NY). A Nationally Certified Advanced Clinical Intervention Professional (NCACIP), he operates a statewide network of treatment navigation, placement, and crisis intervention services across New York, including the Hudson Valley Addiction Treatment Center, Long Island Addiction Treatment Resources, and Every1 Center. He specializes in clinical placement, structured family and executive interventions, and benefits navigation. As an ISSUP Network Moderator, he leads the Integrated Recovery & Intervention Education Network (IRIEN) and authors practical guides and peer-reviewed articles on emerging substance use threats. He also maintains active advocacy membership with the National Alliance on Mental Illness (NAMI).

Medically Reviewed By

Brandon McNally, RN

Registered Nurse (RN) · Medical Reviewer

Registered nurse who reviews clinical content for medical accuracy, ensuring information on 7-OH and kratom dependence, withdrawal, and treatment reflects current evidence-based standards.

References

  1. SAMHSA — Drug-Free Workplace Programs
  2. PubMed — workplace drug testing kratom
  3. MedlinePlus — Kratom
  4. NIDA — Kratom DrugFacts

Medical disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions about a medical condition or substance use. If you are experiencing a medical emergency, call 911.

Related Articles

Call 24/7: 1-800-662-4357